Although inhibition of the RIPK1-RIPK3 necrosome with the combination of low dose of RIPK1 and RIPK3 inhibitors is an effective strategy against diabetes mellitus induced MF, there are several limitations in this study that ought to be addressed. This evidence concerns the gene RIPK1 and diabetes mellitus.